Elizabeth L. Christie

Author

Also Known As

Angela Chou, Angelika N. Christ, Ann-Marie Patch, Anne Hamilton, Christie, Elizabeth L., D. Rischin, E Christie, E. Christie, E.L. Christie, Elaine Sanij

274

Publications

8.4K

Citations

H-Index

Concepts

All Affiliations

Peter MacCallum Cancer Centre The University of Melbourne Walter and Eliza Hall Institute of Medical Research Monash University Memorial Sloan Kettering Cancer Center

About

Elizabeth L. Christie is an author at Peter MacCallum Cancer Centre specializing in medicine, ovarian cancer, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	2.1K
2	Health Sciences	2	2	272
3	Cell Biology	2	2	104
4	Biology	1	1	44
5	Cellular Physiology	1	1	44

Elizabeth L. Christie

Publications

Citations

H-Index

Page 1

	Year	Citations
Whole–genome characterization of chemoresistant ovarian cancer Ann‐Marie Patch, Elizabeth L. Christie, Dariush Etemadmoghadam, Nature MedicineGynecologyCancer GenomicsCancer GeneticsOncology	2015	1.6K
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes Stefan C. Dentro, Ignaty Leshchiner, Kerstin Haase, Cell	2021	520
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns Wei Jiao, Gurnit Atwal, Paz Polak, Nature Communications	2020	230
Reversion of <i>BRCA1/2</i> Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer Elizabeth L. Christie, Sián Fereday, Ken Doig, Journal of Clinical Oncology Purpose Germline Brca1OncologyTumor HeterogeneityCirculating Tumor DnaMedicine	2017	192
Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer Elizabeth L. Christie, Swetansu Pattnaik, Jessica A. Beach, Nature Communications	2019	184
Divergent mutational processes distinguish hypoxic and normoxic tumours Vinayak Bhandari, Constance H. Li, Robert G. Bristow, Nature Communications	2020	141
Sex differences in oncogenic mutational processes Constance H. Li, Stephenie D. Prokopec, Ren Sun, Nature Communications	2020	122
LRP1B Deletion in High-Grade Serous Ovarian Cancers Is Associated with Acquired Chemotherapy Resistance to Liposomal Doxorubicin Prue A. Cowin, Joshy George, Sián Fereday, Cancer Research	2012	110
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer Dale W. Garsed, Ahwan Pandey, Sián Fereday, Nature Genetics Tumor HeterogeneityMedicineImmune LandscapeGynecologyPathology	2022	105
Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer Dale W. Garsed, Kathryn Alsop, Sián Fereday, Clinical Cancer Research	2017	91

Page 1